Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

针对mRNA技术的核心环节抗原序列设计，云顶新耀已完成三代AI算法升级。第一代算法聚焦密码子优化与生产风险控制，第二代实现密码子与RNA二级结构协同优化，而第三代AI模型则整合UTR（非翻译区）与CDS（编码序列）进行联合优化。AI技术赋能的第三代算法模型实现了靶蛋白表达水平大幅提升。

AI技术赋能的第三代算法模型实现了靶蛋白表达水平大幅提升。基于AI+mRNA平台，云顶新耀正在推进mRNA肿瘤药物研发。其中，EVM16是云顶新耀首个进入临床阶段的个性化mRNA肿瘤疫苗。该产品的IIT研究已于2025年3月完成首例患者给药。EVM14是一款通用型现货肿瘤治疗性疫苗，靶向5种肿瘤相关抗原，拟用于鳞状细胞癌的治疗。

The world's first mRNA vaccine against Elephant Endotheliotropic Herpesvirus (EEHV) has reportedly shown promising results, ...

Professor Hirohide Saito (Department of Life Science Frontiers at CiRA / The University of Tokyo) and Assistant Professor ...

The inaccurate rumours refer to a study looking at excess deaths during the pandemic in the German city of Frankfurt am Main.

The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...

Elephant calves at Cincinnati Zoo develop strong antibody responses against EEHV after receiving an innovative mRNA vaccine.

The government’s top vaccine official, working under Health Secretary Robert F. Kennedy Jr., restricted the approval of two ...